Molecular Genetic Analysis of Essential Tremor

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00010549

Enrollment

300

Registered

2016-06-16

Start date

2016-01-16

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G25.0

Interventions

Group 1: With the informed consent, blood samples of the individuals having essential tremor will be obtained. DNA from this blood samples will be used to identify the novel molecular genetic causes o

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Individuals who showed the tremor signs

Exclusion criteria

Exclusion criteria: Individuals who did not show the tremor signs

Design outcomes

Primary

Measure	Time frame
The planned study on further essential tremor families is likely to identify the additional genetic determinants that may add important facts to the emerging network of the involved pathways.	—

Secondary

Measure	Time frame
To understand the identified novel pathways which are involved to cause essential tremor will be instrumental for the development of a better treatment.	—

Countries

Germany, Pakistan

Contacts

Public ContactMuhammad Sajid Hussain,

Zentrum für Biochemie I,

mhussain@uni-koeln.de+49 221-47886853

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026